Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct.
Xiaochuan HuoGaoting MaXu TongXuelei ZhangYue-Song PanThanh N NguyenGuangxiong YuanHongxing HanWenhuo ChenMing WeiJiangang ZhangZhiming ZhouXiaoxi YaoGuoqing WangWeigen SongXueli CaiGuangxian NanDi LiA Yi-Chou WangWentong LingChuwei CaiChangming WenEn WangLiyong ZhangChangchun JiangYajie LiuGeng LiaoXiaohui ChenTianxiao LiShudong LiuJinglun LiFeng GaoNing MaDapeng MoLigang SongXuan SunXiaoqing LiYiming DengGang LuoMing LvHongwei HeAihua LiuJingbo ZhangShiqing MuLian LiuJing JingXiming NieZeyu DingWanliang DuXingquan ZhaoPengfei YangLiping LiuYilong WangDavid S LiebeskindVitor M PereiraZeguang RenYong-Jun WangZhongrong Miaonull nullPublished in: The New England journal of medicine (2023)
In a trial conducted in China, patients with large cerebral infarctions had better outcomes with endovascular therapy administered within 24 hours than with medical management alone but had more intracranial hemorrhages. (Funded by Covidien Healthcare International Trading [Shanghai] and others; ANGEL-ASPECT ClinicalTrials.gov number, NCT04551664.).
Keyphrases
- acute ischemic stroke
- healthcare
- phase iii
- study protocol
- phase ii
- clinical trial
- subarachnoid hemorrhage
- acute myocardial infarction
- open label
- aortic dissection
- type diabetes
- stem cells
- adipose tissue
- skeletal muscle
- acute coronary syndrome
- mesenchymal stem cells
- cerebral ischemia
- blood brain barrier
- health information
- social media
- double blind
- placebo controlled